Who are we?

ALSTEM is a startup biotech company based in the San Francisco Bay Area that specializes in iPS cell reprogramming technology and related products. Founded in early 2012 by a team of scientists with extensive experience in both academic and industrial biotechnology, we are continually looking for ways to improve the quality and usability of our products.

We are an extension of your research team

Our main goal is to identify what difficulties you are encountering during your research and what we can do to simplify the process. ALSTEM aims to have a superb relationship with our clients. We encourage prospective and current customers to contact us so that we can design products and services that are directly tailored to your needs.

Why choose ALSTEM?

Simply put, we want your business and are willing to do whatever it takes to keep it. ALSTEM can cater to your needs. If you don’t see what you’re looking for on the website, please feel free to contact us and we’ll do our best to address your needs. We see our modest size as an advantage because it allows each member of our team to communicate directly with our customers.

Opportunities

We strive to seek partnerships with academic researchers, biotechnological and pharmaceutical companies around the world. We hope to serve the community by providing high-quality products and services at a reasonable price. If you’re interested in forming a partnership with ALSTEM, please contact business development at info@alstembio.com

Partnership with iPS Academia Japan, Inc.

Academia Japan

ALSTEM is one of the select biotech companies to hold the non-exclusive patent agreement with iPS Academia Japan. The alliance allows us to have access to the absolutely critical iPSC patent portfolio founded by the discoveries of Dr. Shinya Yamanaka. Our dedicated focus to iPSC-related technologies is helping ALSTEM become a dominant force in the induced pluripotent stem cell marketplace.